Navigation Links
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers at Molecular Insight Pharmaceuticals today announced the presentation of preclinical data on MIP-1072, a radiolabeled, small molecule molecular imaging pharmaceutical in development for diagnosis and staging of prostate cancer at the 54th annual meeting of the Society of Nuclear Medicine (SNM) in Washington, D.C. MIP-1072 is one of two development candidates for prostate cancer diagnosis that Molecular Insight plans to advance into exploratory human studies in the first half of next year. It is designed to target prostate specific membrane antigen (PSMA), a protein highly expressed by prostate tumor cells. The presentation is one of four on the company's products and technologies to be presented at the meeting.

"Accurate diagnosis and the ability to properly assess the true extent and aggressiveness of prostate cancer are fundamental to appropriate therapeutic management of the disease," said John W. Babich, Ph.D., President and Chief Scientific Officer of Molecular Insight and an author on the study. "Treatment of prostate cancer is challenging, and the effects of treatment may substantially impact a man's quality of life for many years. Therefore, it is crucial that those faced with difficult clinical questions make the right decisions."

"We believe PSMA represents an exceptional target for the molecular imaging of prostate cancer due to its near 100% expression in the disease. Our preclinical studies suggest that MIP-1072 can identify the presence of prostate tumors specifically and non-invasively by targeting PSMA expression on prostate cancer cells. A PSMA-targeted molecular imaging pharmaceutical such as MIP-1072 may lead to improvements in the staging of prostate cancer patients and may represent a unique opportunity to risk stratify patients and monitor response to therapy," he added.

The Society of Nuclear Medicine recognized th
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
3. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
4. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
5. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:5/24/2013)... May 24, 2013  Regulatory and marketplace changes ... many organizations, priority list. Forward-thinking ... understand a strong Medical Affairs function ... development, market education , and regulatory compliance. ... vital bridge between an organization and one of ...
(Date:5/24/2013)... May 24, 2013  BD (Becton, Dickinson and Company) (NYSE: ... announced today that it will present at the Deutsche Bank ... 30, 2013, at 10:40 a.m. (ET). A ... BD corporate website at www.bd.com/investors and will be ... About BD BD is a leading global ...
(Date:5/24/2013)... 2013 /PRNewswire-iReach/ -- Phoenix Houses of California ... organization, is hosting its tenth annual "Triumph For Teens" ... 6, 2013.  More than 300 people are expected to ... residential treatment centers, family therapy, and prevention programs of ... have positive influences on the health and welfare of our ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... scientists today,report that the genetic variant on chromosome ... of heart attack is also associated with up ... (AAA) and intracranial,aneurysm (IA). This is the first ... condition. The paper, entitled ,The same sequence,variant on ...
... Jan. 3 Watson,Pharmaceuticals, Inc. (NYSE: WPI ... has launched Clarithromycin Extended-Release,Tablets, USP in the 500 ... equivalent to Abbott,s Biaxin(R),XL, which is indicated to ... suspected to be caused by susceptible bacteria. For ...
Cached Medicine Technology:Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 2Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 3Watson Launches Generic Biaxin(R) XL 2
(Date:5/24/2013)... Before you start the grill, before you watch the game, ... and Hoda Kotb on the Today Show on Memorial Day. ... Kathie Lee and Hoda, including the new LawnBott® LB75 robotic mower. ... in the military who made the ultimate sacrifice for us. ... friends and family and enjoy the day. With a LawnBott® ...
(Date:5/24/2013)... Mozes HealthDay Reporter , , FRIDAY, May 24 ... accomplishments are remarkable. But it was a physical challenge ... top of her sport. "I was an 11-year-old ... my scoliosis was diagnosed by my orthopedic surgeon," said ... Scoliosis Research Society and the American Academy of Orthopaedic ...
(Date:5/24/2013)... May 24, 2013 ResortQuest Real Estate® ... the Dayna Feher team at the firm’s Bethany Beach ... Delaware resorts her home in 1975. Her real estate ... in all aspects of the real estate business - ... past 12 years, a licensed sales associate. , ...
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group ... more than 59,229 complaints since 2004 from women claiming they ... known as the Mirena IUD.* , Among the most common ... ‘expulsion,’ where the IUD came out on its own. There ... News article. “Abdominal pain is also common, with 3,774 complaints. ...
(Date:5/24/2013)... 24, 2013 CHI-California Healthcare Institute ... the California congressional delegation, joined by over 40 ... user fees paid to the U.S. Food and ... future across-the-board cuts will not include user fees ... Agriculture, Rural Development and FDA Appropriations Bill. CHI ...
Breaking Medicine News(10 mins):Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3
... 2009 A new study published in Value ... in the U.S. and recent clinical findings of the ... the history of economic articles published on migraine using ... articles to identify possible health risks associated with migraines ...
... met its match. A tiny molecule, quercetin, found in most plant-based foods douses the flames before damaging lesions ... Click here for more information. , , ... , , , , ... , , , , ...
... SANTA MONICA, Calif., Feb. 2 A national consumer ... lobbying positions on the electronic medical record provisions of ... an independent journalist that Google,s presence on the bill ... public policy team for an immediate answer. The letter ...
... Ga., Feb. 2 Aflac Incorporated today,reported its fourth quarter ... the strengthening of the yen to the dollar,in the fourth ... the fourth quarter of 2007. Net earnings were $197 ... $.78 per share, a year ago. , ...
... Feb. 2 Rochester Medical Corporation (Nasdaq: ROCM ... December 31, 2008.The Company reported sales of $8,436,000 for the ... last year. It also reported net income of $54,000 ... $272,000 or $.02 per diluted share for the first quarter ...
... Calif., Feb. 2 In conjunction with DURECT ... 2008 financial results press release, you are invited ... be broadcast live over the Internet on Monday, ... PST).(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )A live audio webcast of ...
Cached Medicine News:Health News:Study reviews health risks, economic burden of migraine 2Health News:Inflammation in colon may get doused before fueling cancer development 2Health News:Inflammation in colon may get doused before fueling cancer development 3Health News:Inflammation in colon may get doused before fueling cancer development 4Health News:Inflammation in colon may get doused before fueling cancer development 5Health News:Consumer Watchdog to Google: Publicly Disclose Your Lobbying Positions on Electronic Medical Record Provisions in Stimulus Bill 2Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 2Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 3Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 4Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 5Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 6Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 7Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 8Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 9Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 10Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 11Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 12Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 13Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 14Health News:Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target 15Health News:Rochester Medical Reports First Quarter Results 2Health News:Rochester Medical Reports First Quarter Results 3Health News:Rochester Medical Reports First Quarter Results 4Health News:Rochester Medical Reports First Quarter Results 5Health News:Rochester Medical Reports First Quarter Results 6Health News:Rochester Medical Reports First Quarter Results 7Health News:Rochester Medical Reports First Quarter Results 8Health News:DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call 2
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
BD Vacutainer® Specialty Tubes - Other - Plastic...
The Erythrocyte Sedimentation Rate (ESR) can be used as a nonspecific search technique in case of suspicion of inflammatory reactions as well as for judgement of their development. VACUETTE® ESR...
Inquire...
Medicine Products: